Pub Date : 2025-07-23eCollection Date: 2025-10-01DOI: 10.1093/skinhd/vzaf049
Hissa Al-Marri, Wadha Al-Shafi, Mohammed Al-Abdula, Mohammed Al-Jaber, Ayda AlHammadi, Aysha Al-Malki, Hanof Ahmed, Maryam Al-Jaidah, Fatima Al-Khawaja, Seena Manjooran, Febu Joy, Fareed Ahmad, Joerg Buddenkotte, Martin Steinhoff
Photodermatoses represent a varied collection of skin disorders characterized by cutaneous reactions provoked by exposure to ultraviolet radiation. The disease mechanism is based on an immune-mediated delayed hypersensitivity reaction. Clinical presentation of patients with photodermatosis includes pigmentary changes, erythema and/or lichenification, with interindividual differences in lesion morphology and distribution. Most patients report associated symptoms of burning sensation and itchiness as their chief complaint, severely affecting their quality of life. Management of photodermatoses involves both preventive measures and medical management applying topical steroids and calcineurin inhibitors, or systemic immunosuppressives, with variable degree of success and adverse events. Here, we report three cases of chronic photodermatitis treated with upadacitinib, a selective Janus kinase 1 inhibitor, as monotherapy, which resulted in fast, significant and sustainable improvement of signs and symptoms, with a favourable safety and tolerability profile.
{"title":"Three cases of chronic photodermatitis successfully treated with upadacitinib.","authors":"Hissa Al-Marri, Wadha Al-Shafi, Mohammed Al-Abdula, Mohammed Al-Jaber, Ayda AlHammadi, Aysha Al-Malki, Hanof Ahmed, Maryam Al-Jaidah, Fatima Al-Khawaja, Seena Manjooran, Febu Joy, Fareed Ahmad, Joerg Buddenkotte, Martin Steinhoff","doi":"10.1093/skinhd/vzaf049","DOIUrl":"10.1093/skinhd/vzaf049","url":null,"abstract":"<p><p>Photodermatoses represent a varied collection of skin disorders characterized by cutaneous reactions provoked by exposure to ultraviolet radiation. The disease mechanism is based on an immune-mediated delayed hypersensitivity reaction. Clinical presentation of patients with photodermatosis includes pigmentary changes, erythema and/or lichenification, with interindividual differences in lesion morphology and distribution. Most patients report associated symptoms of burning sensation and itchiness as their chief complaint, severely affecting their quality of life. Management of photodermatoses involves both preventive measures and medical management applying topical steroids and calcineurin inhibitors, or systemic immunosuppressives, with variable degree of success and adverse events. Here, we report three cases of chronic photodermatitis treated with upadacitinib, a selective Janus kinase 1 inhibitor, as monotherapy, which resulted in fast, significant and sustainable improvement of signs and symptoms, with a favourable safety and tolerability profile.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 5","pages":"389-393"},"PeriodicalIF":0.0,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12480731/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145208634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-23eCollection Date: 2025-10-01DOI: 10.1093/skinhd/vzaf042
Augustin C Barolet, Daniel Barolet
Background: Rhinophyma, a progressive nasal deformity resulting from advanced rosacea, presents significant cosmetic and functional challenges. Fully ablative CO2 laser therapy is a recognized treatment modality, but data on its long-term efficacy and safety, and recurrence rates remain limited.
Objectives: To assess the long-term outcomes, safety and patient satisfaction associated with fully ablative CO2 laser therapy for rhinophyma and to identify predictors of treatment success using an artificial intelligence (AI)-assisted model.
Methods: A retrospective study was conducted on 152 patients with rhinophyma (grades I-III) treated with CO2 laser therapy at an outpatient clinic affiliated with McGill University. Patients were evaluated for aesthetic improvement using the Global Aesthetic Improvement Scale (GAIS), satisfaction surveys and follow-up assessments at 1, 3, 6 and 12 months post-treatment. Demographic and clinical data were analysed using descriptive statistics, logistic regression and a deep learning model to determine predictors of hypopigmentation, recurrence and patient outcomes.
Results: Significant aesthetic improvement (GAIS ≥ 3) was observed in 84% of p atients, with an average satisfaction score of 2.51/3. Recurrence was rare (4%), occurring primarily in older men with grade III rhinophyma. Side effects included mild hypopigmentation (9%) and textural changes (2%). A deep learning model identified rhinophyma grade, age and Fitzpatrick phototype as key predictors of treatment outcomes. Logistic regression confirmed that advanced rhinophyma grades significantly reduced hypopigmentation risk [adjusted odds ratio (aOR) 0.43, 95% confidence interval (CI) 0.18-0.97; P = 0.041], while age significantly increased it (aOR 1.08, 95% CI 1.00-1.17, P = 0.026). Higher rhinophyma grades were also strongly associated with increased patient satisfaction (aOR 4.97, 95% CI 2.79-9.48; P < 0.001) and showed a trend toward higher recurrence risk (aOR = 6.11, 95% CI: 0.92-690.69, P = 0.064). Fitzpatrick phototype was significantly associated with patient satisfaction; decreasing Fitzpatrick phototype was associated with reduced odds of patient-reported satisfaction (aOR 0.48, 95% CI 0.25-0.87; P = 0.015).
Conclusions: Fully ablative CO2 laser therapy is highly effective and safe for rhinophyma, with most patients achieving significant improvements after a single session. AI-assisted analysis provides valuable insights into predictors of success, enabling personalized treatment plans. Older patients had an 8% increased risk of hypopigmentation per year of age, while patients with severe rhinophyma were at lower risk of hypopigmentation but at higher risk of recurrence. These findings reinforce the role of CO2 laser therapy as a cornerstone treatment f
背景:鼻肿是一种由晚期酒渣鼻引起的进行性鼻畸形,对美容和功能提出了重大挑战。完全消融CO2激光治疗是一种公认的治疗方式,但关于其长期疗效和安全性以及复发率的数据仍然有限。目的:评估鼻肿完全消融CO2激光治疗的长期结果、安全性和患者满意度,并利用人工智能(AI)辅助模型确定治疗成功的预测因素。方法:对麦吉尔大学附属门诊接受CO2激光治疗的152例I-III级鼻肿患者进行回顾性研究。采用全球美学改善量表(GAIS)、满意度调查和治疗后1、3、6和12个月的随访评估对患者的美学改善进行评估。使用描述性统计、逻辑回归和深度学习模型分析人口统计学和临床数据,以确定色素沉着减少、复发和患者预后的预测因素。结果:84%的患者美观度有显著改善(GAIS≥3),平均满意度为2.51/3。复发罕见(4%),主要发生在患有III级鼻肿的老年男性。副作用包括轻度色素沉着(9%)和质地改变(2%)。深度学习模型确定鼻肿分级、年龄和菲茨帕特里克光型是治疗结果的关键预测因素。Logistic回归证实晚期鼻肿分级显著降低色素沉着风险[调整优势比(aOR) 0.43, 95%可信区间(CI) 0.18-0.97;P = 0.041],年龄显著增加(aOR 1.08, 95% CI 1.00 ~ 1.17, P = 0.026)。鼻肿分级越高,患者满意度越高(aOR = 4.97, 95% CI 2.79-9.48; P < 0.001),复发风险越高(aOR = 6.11, 95% CI: 0.92-690.69, P = 0.064)。Fitzpatrick照相术与患者满意度显著相关;Fitzpatrick光型的减少与患者报告满意度的降低相关(aOR 0.48, 95% CI 0.25-0.87; P = 0.015)。结论:完全消融CO2激光治疗鼻肿是非常有效和安全的,大多数患者在单次治疗后获得显着改善。人工智能辅助分析为预测成功提供了有价值的见解,从而实现了个性化的治疗计划。老年患者色素减退的风险每年增加8%,而严重鼻肿患者色素减退的风险较低,但复发风险较高。这些发现强化了CO2激光治疗作为鼻肿基础治疗的作用,同时强调了预测分析在指导治疗策略中的效用。
{"title":"Fully ablative CO<sub>2</sub> laser therapy for rhinophyma: long-term efficacy, safety and insights from an artificial intelligence-assisted predictive model in a large cohort.","authors":"Augustin C Barolet, Daniel Barolet","doi":"10.1093/skinhd/vzaf042","DOIUrl":"10.1093/skinhd/vzaf042","url":null,"abstract":"<p><strong>Background: </strong>Rhinophyma, a progressive nasal deformity resulting from advanced rosacea, presents significant cosmetic and functional challenges. Fully ablative CO<sub>2</sub> laser therapy is a recognized treatment modality, but data on its long-term efficacy and safety, and recurrence rates remain limited.</p><p><strong>Objectives: </strong>To assess the long-term outcomes, safety and patient satisfaction associated with fully ablative CO<sub>2</sub> laser therapy for rhinophyma and to identify predictors of treatment success using an artificial intelligence (AI)-assisted model.</p><p><strong>Methods: </strong>A retrospective study was conducted on 152 patients with rhinophyma (grades I-III) treated with CO<sub>2</sub> laser therapy at an outpatient clinic affiliated with McGill University. Patients were evaluated for aesthetic improvement using the Global Aesthetic Improvement Scale (GAIS), satisfaction surveys and follow-up assessments at 1, 3, 6 and 12 months post-treatment. Demographic and clinical data were analysed using descriptive statistics, logistic regression and a deep learning model to determine predictors of hypopigmentation, recurrence and patient outcomes.</p><p><strong>Results: </strong>Significant aesthetic improvement (GAIS ≥ 3) was observed in 84% of p atients, with an average satisfaction score of 2.51/3. Recurrence was rare (4%), occurring primarily in older men with grade III rhinophyma. Side effects included mild hypopigmentation (9%) and textural changes (2%). A deep learning model identified rhinophyma grade, age and Fitzpatrick phototype as key predictors of treatment outcomes. Logistic regression confirmed that advanced rhinophyma grades significantly reduced hypopigmentation risk [adjusted odds ratio (aOR) 0.43, 95% confidence interval (CI) 0.18-0.97; <i>P</i> = 0.041], while age significantly increased it (aOR 1.08, 95% CI 1.00-1.17, <i>P</i> = 0.026). Higher rhinophyma grades were also strongly associated with increased patient satisfaction (aOR 4.97, 95% CI 2.79-9.48; <i>P</i> < 0.001) and showed a trend toward higher recurrence risk (aOR = 6.11, 95% CI: 0.92-690.69, <i>P</i> = 0.064). Fitzpatrick phototype was significantly associated with patient satisfaction; decreasing Fitzpatrick phototype was associated with reduced odds of patient-reported satisfaction (aOR 0.48, 95% CI 0.25-0.87; <i>P</i> = 0.015).</p><p><strong>Conclusions: </strong>Fully ablative CO<sub>2</sub> laser therapy is highly effective and safe for rhinophyma, with most patients achieving significant improvements after a single session. AI-assisted analysis provides valuable insights into predictors of success, enabling personalized treatment plans. Older patients had an 8% increased risk of hypopigmentation per year of age, while patients with severe rhinophyma were at lower risk of hypopigmentation but at higher risk of recurrence. These findings reinforce the role of CO<sub>2</sub> laser therapy as a cornerstone treatment f","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 5","pages":"357-367"},"PeriodicalIF":0.0,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12480734/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145208676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This case report presents a rare occurrence of pigmented demodicosis in a 59-year-old woman with Fitzpatrick skin type IV, who presented with pruritic and progressively pigmented plaques over her cheeks and eyelids. Dermoscopic examination and skin biopsy confirmed the presence of Demodex mites in the hair follicles. Treatment with topical ivermectin led to marked improvement, highlighting the importance of considering this condition in cases of facial hyperpigmentation and the efficacy of antidemodectic therapies.
{"title":"A striking case of pigmented demodicosis.","authors":"Shanxi Jen, Lydia Tang-Lin, Sze Hwa Tan, Wei Liang Koh","doi":"10.1093/skinhd/vzaf054","DOIUrl":"10.1093/skinhd/vzaf054","url":null,"abstract":"<p><p>This case report presents a rare occurrence of pigmented demodicosis in a 59-year-old woman with Fitzpatrick skin type IV, who presented with pruritic and progressively pigmented plaques over her cheeks and eyelids. Dermoscopic examination and skin biopsy confirmed the presence of <i>Demodex</i> mites in the hair follicles. Treatment with topical ivermectin led to marked improvement, highlighting the importance of considering this condition in cases of facial hyperpigmentation and the efficacy of antidemodectic therapies.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 5","pages":"386-388"},"PeriodicalIF":0.0,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12480740/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145208617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-08eCollection Date: 2025-10-01DOI: 10.1093/skinhd/vzaf034
Ronald Mbiine, Misaki Wayengera, Noah Kiwanuka, Ian G Munabi, Haruna Muwonge, Cephas Nakanwagi, Biratu Olika, Lekuya Herve Monka, Moses Joloba, Moses Galukande
Background: Keloids are among the leading benign skin conditions globally, affecting up to 16% of the African population. They are characterized by aggressive behaviour, high recurrence rates and poor treatment outcomes, particularly in African populations. Despite this, most information on keloids in sub-Saharan Africa remains anecdotal, with limited comprehensive studies describing their clinical and pathological characteristics.
Objectives: To analyse the clinical and histopathological features of keloids in a sub-Saharan African population.
Methods: Following ethical approval, 231 participants were enrolled in a cross-sectional study conducted at the 2 national referral plastic surgical centres in Uganda. Data on demographics, clinical presentations and histopathological features of keloids were collected and analysed.
Results: Sixty-four per cent of participants (n = 148/231) were women, 63.3% (n = 133/210) resided in central Uganda and 82.3% (n = 190/231) belonged to the Bantu ethnic group, with those belonging to the Baganda tribe predominating (n = 97/231; 42.0%). Keloids were broadly classified into sessile (n = 116/231; 50.2%) and nodular types. The most frequently affected anatomical sites were the head and neck (n = 106/231; 45.9%) and the trunk (n = 52/231; 22.5%). Additionally, 58.0% (n = 134/231) of participants had multiple keloids. Histopathological analysis of 35 excised specimens revealed that keloids are primarily a dermal disease, characterized by excessive collagen deposition, particularly hyalinized collagen.
Conclusions: Keloids in African populations exhibit a slight female predominance, a tendency toward multiplicity and larger lesion volumes. Histopathological findings highlight excessive collagen deposition as a hallmark, emphasizing the need for tailored approaches to improve treatment outcomes.
{"title":"Description of clinical and histopathological characteristics of keloids in a sub-Saharan African population.","authors":"Ronald Mbiine, Misaki Wayengera, Noah Kiwanuka, Ian G Munabi, Haruna Muwonge, Cephas Nakanwagi, Biratu Olika, Lekuya Herve Monka, Moses Joloba, Moses Galukande","doi":"10.1093/skinhd/vzaf034","DOIUrl":"10.1093/skinhd/vzaf034","url":null,"abstract":"<p><strong>Background: </strong>Keloids are among the leading benign skin conditions globally, affecting up to 16% of the African population. They are characterized by aggressive behaviour, high recurrence rates and poor treatment outcomes, particularly in African populations. Despite this, most information on keloids in sub-Saharan Africa remains anecdotal, with limited comprehensive studies describing their clinical and pathological characteristics.</p><p><strong>Objectives: </strong>To analyse the clinical and histopathological features of keloids in a sub-Saharan African population.</p><p><strong>Methods: </strong>Following ethical approval, 231 participants were enrolled in a cross-sectional study conducted at the 2 national referral plastic surgical centres in Uganda. Data on demographics, clinical presentations and histopathological features of keloids were collected and analysed.</p><p><strong>Results: </strong>Sixty-four per cent of participants (<i>n</i> = 148/231) were women, 63.3% (<i>n</i> = 133/210) resided in central Uganda and 82.3% (<i>n</i> = 190/231) belonged to the Bantu ethnic group, with those belonging to the Baganda tribe predominating (<i>n</i> = 97/231; 42.0%). Keloids were broadly classified into sessile (<i>n</i> = 116/231; 50.2%) and nodular types. The most frequently affected anatomical sites were the head and neck (<i>n</i> = 106/231; 45.9%) and the trunk (<i>n</i> = 52/231; 22.5%). Additionally, 58.0% (<i>n</i> = 134/231) of participants had multiple keloids. Histopathological analysis of 35 excised specimens revealed that keloids are primarily a dermal disease, characterized by excessive collagen deposition, particularly hyalinized collagen.</p><p><strong>Conclusions: </strong>Keloids in African populations exhibit a slight female predominance, a tendency toward multiplicity and larger lesion volumes. Histopathological findings highlight excessive collagen deposition as a hallmark, emphasizing the need for tailored approaches to improve treatment outcomes.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 5","pages":"326-343"},"PeriodicalIF":0.0,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12480727/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145208638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01eCollection Date: 2025-08-01DOI: 10.1093/skinhd/vzaf048
Ki Wei Tan, Sze Hwa Tan
This case vignette describes a 74-year-old patient with cutaneous metastases to the scalp from renal cell carcinoma. It highlights the histological and immunohistochemical findings in cutaneous metastatic renal cell carcinoma and the good response of the scalp metastasis to chemotherapy.
{"title":"Cutaneous scalp metastasis from renal cell carcinoma with excellent response to chemotherapy.","authors":"Ki Wei Tan, Sze Hwa Tan","doi":"10.1093/skinhd/vzaf048","DOIUrl":"10.1093/skinhd/vzaf048","url":null,"abstract":"<p><p>This case vignette describes a 74-year-old patient with cutaneous metastases to the scalp from renal cell carcinoma. It highlights the histological and immunohistochemical findings in cutaneous metastatic renal cell carcinoma and the good response of the scalp metastasis to chemotherapy.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 4","pages":"309"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12311158/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144777110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01eCollection Date: 2025-08-01DOI: 10.1093/skinhd/vzaf051
Jonathan Guckian, Olivia Hughes, Yasmin Nikookam, Ria Nair, Aqua Asif, Jeremy Brown, Anthony Bewley, Faheem Latheef
Background: Consensus amongst dermatologists regarding the phenomenon of topical steroid withdrawal (TSW) is elusive. This may be contrasted with a growing online patient movement, including social media communities.
Objectives: This study aimed to investigate dermatologist perspectives regarding TSW and to assess attitudes towards self-diagnosis.
Methods: A two-part online questionnaire was disseminated to UK-based Dermatology Consultants, Registrars and Fellows. Section one presented a clinical scenario and randomized respondents into two groups: one mentioning TSW self-diagnosis, and an otherwise identical control without the self-diagnosis. Questions about the clinical scenario were directed to dermatologists and focused on attitudes regarding patient-predicted behaviours. Section two asked about TSW perceptions and experiences, and thematic analysis of open text responses was undertaken.
Results: One hundred and three responses were received, including 51 Consultants, 38 Trainee Dermatologists, 10 Dermatology Fellows, 3 Specialty And Specialist (SAS) Dermatology doctors and 1 Post-CCT (Certificate of Completion of Training) Fellow. Thirty-four percent (n = 35/103) of respondents considered TSW to be a distinct clinical entity, 17.5% (n = 18/103) did not and 48.5% (n = 50/103) were unsure. Respondents felt that self-diagnosing TSW patients were less likely to comply with treatment, and more likely to take up time and pose management problems compared with controls. Themes of uncertainty regarding diagnostic veracity and social media misinformation were identified.
Conclusions: Uncertainty regarding the veracity of a TSW diagnosis and its management is common amongst dermatology healthcare professionals (HCPs). Dermatology HCPs in this study considered that patients who self-diagnosed TSW were more difficult to engage with skin disease management. Dermatologists desire further understanding of and research into the nature and management of TSW.
{"title":"Topical steroid withdrawal: self-diagnosis, unconscious bias and social media.","authors":"Jonathan Guckian, Olivia Hughes, Yasmin Nikookam, Ria Nair, Aqua Asif, Jeremy Brown, Anthony Bewley, Faheem Latheef","doi":"10.1093/skinhd/vzaf051","DOIUrl":"10.1093/skinhd/vzaf051","url":null,"abstract":"<p><strong>Background: </strong>Consensus amongst dermatologists regarding the phenomenon of topical steroid withdrawal (TSW) is elusive. This may be contrasted with a growing online patient movement, including social media communities.</p><p><strong>Objectives: </strong>This study aimed to investigate dermatologist perspectives regarding TSW and to assess attitudes towards self-diagnosis.</p><p><strong>Methods: </strong>A two-part online questionnaire was disseminated to UK-based Dermatology Consultants, Registrars and Fellows. Section one presented a clinical scenario and randomized respondents into two groups: one mentioning TSW self-diagnosis, and an otherwise identical control without the self-diagnosis. Questions about the clinical scenario were directed to dermatologists and focused on attitudes regarding patient-predicted behaviours. Section two asked about TSW perceptions and experiences, and thematic analysis of open text responses was undertaken.</p><p><strong>Results: </strong>One hundred and three responses were received, including 51 Consultants, 38 Trainee Dermatologists, 10 Dermatology Fellows, 3 Specialty And Specialist (SAS) Dermatology doctors and 1 Post-CCT (Certificate of Completion of Training) Fellow. Thirty-four percent (<i>n</i> = 35/103) of respondents considered TSW to be a distinct clinical entity, 17.5% (<i>n</i> = 18/103) did not and 48.5% (<i>n</i> = 50/103) were unsure. Respondents felt that self-diagnosing TSW patients were less likely to comply with treatment, and more likely to take up time and pose management problems compared with controls. Themes of uncertainty regarding diagnostic veracity and social media misinformation were identified.</p><p><strong>Conclusions: </strong>Uncertainty regarding the veracity of a TSW diagnosis and its management is common amongst dermatology healthcare professionals (HCPs). Dermatology HCPs in this study considered that patients who self-diagnosed TSW were more difficult to engage with skin disease management. Dermatologists desire further understanding of and research into the nature and management of TSW.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 4","pages":"281-288"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12311166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144777117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-25eCollection Date: 2025-08-01DOI: 10.1093/skinhd/vzaf045
Veronika Zenderowski, James A Hutchinson, Andreas Brosig, Sebastian Haferkamp, Katharina Kronenberg
Immune-related adverse events (irAE) are common in checkpoint blockade-treated patients and limit its clinical application. Corticosteroids are the first-line therapy for treatment of irAE, but animal models clearly demonstrate that steroids diminish anti-programmed cell death protein 1 (PD-1)-induced tumour immunity. Better strategies to manage irAE while preserving anti-tumour immunity are needed. Extracorporeal photopheresis (ECP) was recently introduced as second-line treatment for steroid-refractory immune checkpoint inhibitor (ICI)-related colitis and hepatitis. Here, we extend the application of ECP to immune-related maculopapular rash after adjuvant anti-PD-1 therapy in a single melanoma patient. The patient's dermatitis markedly improved after off-label ECP, with a substantial reduction in skin lesions and pruritus scores, and stabilization of immune markers. The patient remained well after ECP with no recurrent or metastatic disease at 14 months after starting ECP treatment. Hence, in this case, ECP led to successful resolution of pembrolizumab-induced dermatitis and a favourable oncological outcome.
{"title":"Extracorporeal photopheresis for pembrolizumab-induced dermatitis: a case report.","authors":"Veronika Zenderowski, James A Hutchinson, Andreas Brosig, Sebastian Haferkamp, Katharina Kronenberg","doi":"10.1093/skinhd/vzaf045","DOIUrl":"10.1093/skinhd/vzaf045","url":null,"abstract":"<p><p>Immune-related adverse events (irAE) are common in checkpoint blockade-treated patients and limit its clinical application. Corticosteroids are the first-line therapy for treatment of irAE, but animal models clearly demonstrate that steroids diminish anti-programmed cell death protein 1 (PD-1)-induced tumour immunity. Better strategies to manage irAE while preserving anti-tumour immunity are needed. Extracorporeal photopheresis (ECP) was recently introduced as second-line treatment for steroid-refractory immune checkpoint inhibitor (ICI)-related colitis and hepatitis. Here, we extend the application of ECP to immune-related maculopapular rash after adjuvant anti-PD-1 therapy in a single melanoma patient. The patient's dermatitis markedly improved after off-label ECP, with a substantial reduction in skin lesions and pruritus scores, and stabilization of immune markers. The patient remained well after ECP with no recurrent or metastatic disease at 14 months after starting ECP treatment. Hence, in this case, ECP led to successful resolution of pembrolizumab-induced dermatitis and a favourable oncological outcome.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 4","pages":"293-296"},"PeriodicalIF":0.0,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12311163/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144777112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-25eCollection Date: 2025-08-01DOI: 10.1093/skinhd/vzaf044
Vasilina Tambovskaya, Luis Escalante, Astrid Maldonado, Maria Antonieta Touriz Bonifaz, Edgar Escalante
Endometriosis is defined as the presence of endometrial tissue (glands and stroma) outside the uterine cavity. Various organs can be affected, including the skin. Umbilical endometriosis is the most common clinical form of extrapelvic endometriosis and the most frequent type of cutaneous endometriosis, classified into primary and secondary forms. The primary or spontaneous form is rare, occurring without any prior surgical intervention, with a predilection for the umbilical area.
{"title":"Spontaneous umbilical endometriosis.","authors":"Vasilina Tambovskaya, Luis Escalante, Astrid Maldonado, Maria Antonieta Touriz Bonifaz, Edgar Escalante","doi":"10.1093/skinhd/vzaf044","DOIUrl":"10.1093/skinhd/vzaf044","url":null,"abstract":"<p><p>Endometriosis is defined as the presence of endometrial tissue (glands and stroma) outside the uterine cavity. Various organs can be affected, including the skin. Umbilical endometriosis is the most common clinical form of extrapelvic endometriosis and the most frequent type of cutaneous endometriosis, classified into primary and secondary forms. The primary or spontaneous form is rare, occurring without any prior surgical intervention, with a predilection for the umbilical area.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 4","pages":"307-308"},"PeriodicalIF":0.0,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12311160/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144777115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-25eCollection Date: 2025-08-01DOI: 10.1093/skinhd/vzaf043
Claire Doyle, Anne-Marie Tobin, Tony Foley
Background: Despite a high frequency of presentations of skin disease in primary care, research has demonstrated a paucity of dermatology teaching in the medical school curriculum and a variable level of postgraduate dermatology teaching in general practice training. While it is clear that general practitioner (GP) trainees feel they would benefit from additional dermatology teaching, there is a gap in the literature regarding the factors that influence their learning.
Objectives: The aim of this study was to identify and examine factors that influence the dermatology learning of GP trainees.
Methods: A qualitative study of GP trainees in their third and fourth year of their training scheme practising in Ireland was undertaken. Full ethical approval was obtained prior to commencement. Semi-structured interviews were conducted with participants via Microsoft Teams. Participants were sampled using a combination of purposive, convenience and snowball sampling. Interviews were audio-recorded and transcribed verbatim. Data were analysed inductively by employing thematic analysis.
Results: Fourteen GP trainees from five GP training schemes in Ireland participated in the study. Emergent themes identified factors that influence the dermatology learning of GP trainees in Ireland. These factors include experiential learning, competing demands, the clinical learning environment and mixed emotions towards dermatology. These influences mainly had a positive effect on the dermatology learning of trainees but certain competing demands such as time and incongruent teaching were felt to hinder their learning.
Conclusion: This study broadens our understanding of factors that influence the dermatology learning of GP trainees. Findings generated from this study may be utilized to improve the clinical learning environment and inform the dermatology curriculum of GP trainees.
{"title":"'I'm definitely more confident now': a qualitative study exploring how GP trainees learn about dermatology.","authors":"Claire Doyle, Anne-Marie Tobin, Tony Foley","doi":"10.1093/skinhd/vzaf043","DOIUrl":"10.1093/skinhd/vzaf043","url":null,"abstract":"<p><strong>Background: </strong>Despite a high frequency of presentations of skin disease in primary care, research has demonstrated a paucity of dermatology teaching in the medical school curriculum and a variable level of postgraduate dermatology teaching in general practice training. While it is clear that general practitioner (GP) trainees feel they would benefit from additional dermatology teaching, there is a gap in the literature regarding the factors that influence their learning.</p><p><strong>Objectives: </strong>The aim of this study was to identify and examine factors that influence the dermatology learning of GP trainees.</p><p><strong>Methods: </strong>A qualitative study of GP trainees in their third and fourth year of their training scheme practising in Ireland was undertaken. Full ethical approval was obtained prior to commencement. Semi-structured interviews were conducted with participants via Microsoft Teams. Participants were sampled using a combination of purposive, convenience and snowball sampling. Interviews were audio-recorded and transcribed verbatim. Data were analysed inductively by employing thematic analysis.</p><p><strong>Results: </strong>Fourteen GP trainees from five GP training schemes in Ireland participated in the study. Emergent themes identified factors that influence the dermatology learning of GP trainees in Ireland. These factors include experiential learning, competing demands, the clinical learning environment and mixed emotions towards dermatology. These influences mainly had a positive effect on the dermatology learning of trainees but certain competing demands such as time and incongruent teaching were felt to hinder their learning.</p><p><strong>Conclusion: </strong>This study broadens our understanding of factors that influence the dermatology learning of GP trainees. Findings generated from this study may be utilized to improve the clinical learning environment and inform the dermatology curriculum of GP trainees.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 4","pages":"273-280"},"PeriodicalIF":0.0,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12311167/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144777113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Actinomycetoma is a chronic, progressive bacterial infection characterized by granuloma formation, with Nocardia vulneris being a rare causative agent. A 32-year-old healthy man from El Salvador presented with painless nodules, scars and discharging sinus tracts on his back. Examination of the exudate revealed small white grains, and Nocardia species were isolated through culture. Molecular identification of N. vulneris was confirmed via 16S rDNA gene amplification and sequencing. The patient was treated with trimethoprim-sulfamethoxazole and dapsone, resulting in significant clinical improvement after 6 months. He continues on this treatment regimen. This case highlights the rarity of N. vulneris mycetoma at an unusual anatomical site and demonstrates the effectiveness of combined trimethoprim-sulfamethoxazole and dapsone therapy.
{"title":"<i>Nocardia vulneris</i>: a rare pathogen in actinomycetoma - a case report and review of the literature.","authors":"Teerapong Rattananukrom, Roberto Arenas, Yosbeli Ramírez, Ana Luz Ely Guevara-Cerritos, Rigoberto Hernandez-Castro","doi":"10.1093/skinhd/vzaf041","DOIUrl":"10.1093/skinhd/vzaf041","url":null,"abstract":"<p><p>Actinomycetoma is a chronic, progressive bacterial infection characterized by granuloma formation, with <i>Nocardia vulneris</i> being a rare causative agent. A 32-year-old healthy man from El Salvador presented with painless nodules, scars and discharging sinus tracts on his back. Examination of the exudate revealed small white grains, and <i>Nocardia</i> species were isolated through culture. Molecular identification of <i>N. vulneris</i> was confirmed via 16S rDNA gene amplification and sequencing. The patient was treated with trimethoprim-sulfamethoxazole and dapsone, resulting in significant clinical improvement after 6 months. He continues on this treatment regimen. This case highlights the rarity of <i>N. vulneris</i> mycetoma at an unusual anatomical site and demonstrates the effectiveness of combined trimethoprim-sulfamethoxazole and dapsone therapy.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 4","pages":"297-302"},"PeriodicalIF":0.0,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12311168/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144777183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}